Perspectives on Adapting a Mobile Application for Pain Self-management in Neurofibromatosis Type 1: Results of Online Focus Group Discussions with Individuals Living with Neurofibromatosis Type 1 and Pain Management Experts

Overview

Journal BMJ Open

Specialty General Medicine

Date 2022 Jul 15

PMID 35840301

Authors

Lauretta E Grau

Kaitlyn Larkin

Chitra Lalloo

Jennifer N Stinson

William T Zempsky

Samuel A Ball

Frank D Buono

Affiliations

Soon will be listed here.

Abstract

Objective: Neurofibromatosis type 1 (NF1) is a genetic disorder in which chronic pain commonly occurs. The study sought to understand the needs of individuals with NF1 and pain management experts when adapting a pain self-management mobile health application (app) for individuals with NF1.

Design: We conducted a series of online, audio-recorded focus groups that were then thematically analysed.

Setting: Online focus groups with adults currently residing in the USA.

Participants: Two types of participants were included: individuals with NF1 (n=32 across six focus groups) and pain management experts (n=10 across three focus groups).

Results: Six themes across two levels were identified. The individual level included lifestyle, reasons for using the mobile app and concerns regarding its use. The app level included desired content, desired features and format considerations. Findings included recommendations to grant free access to the app and include a community support feature for individuals to relate and validate one another's experience with pain from NF1. In addition, participants noted the importance of providing clear instructions on navigating the app, the use of an upbeat, hopeful tone and appropriate visuals.

Conclusions: Both participant groups endorsed the use of iCanCope (iCC) as an NF1 pain self-management mobile app. Differences between groups were noted, however. The NF1 group appeared interested in detailed and nuanced pain tracking capabilities; the expert group prioritised tracking information such as mood, nutrition and activity to identify potential associations with pain. In tailoring the existing iCC app for individuals with NF1, attention should be paid to creating a community support group feature and to tailoring content, features and format to potential users' specific needs.

Citing Articles

Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.

Wolters P, Al Ghriwati N, Baker M, Martin S, Berg D, Erickson G Clin Trials. 2023; 21(1):73-84.

PMID: 37962219 PMC: 10922214. DOI: 10.1177/17407745231209224.

References

Llorens-Vernet P, Miro J . Standards for Mobile Health-Related Apps: Systematic Review and Development of a Guide. JMIR Mhealth Uhealth. 2020; 8(3):e13057. PMC: 7078629. DOI: 10.2196/13057. View

Young S, Holloway I, Jaganath D, Rice E, Westmoreland D, Coates T . Project HOPE: online social network changes in an HIV prevention randomized controlled trial for African American and Latino men who have sex with men. Am J Public Health. 2014; 104(9):1707-12. PMC: 4151951. DOI: 10.2105/AJPH.2014.301992. View

Stinson J, White M, Isaac L, Campbell F, Brown S, Ruskin D . Understanding the information and service needs of young adults with chronic pain: perspectives of young adults and their providers. Clin J Pain. 2013; 29(7):600-12. DOI: 10.1097/AJP.0b013e31826dce65. View

Brems H, Beert E, de Ravel T, Legius E . Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 2009; 10(5):508-15. DOI: 10.1016/S1470-2045(09)70033-6. View

Martin S, Wolters P, Toledo-Tamula M, Nelson Schmitt S, Baldwin A, Starosta A . Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy. Am J Med Genet A. 2016; 170(6):1462-70. PMC: 6675568. DOI: 10.1002/ajmg.a.37623. View

Vranceanu A, Merker V, Park E, Plotkin S . Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature. J Neurooncol. 2013; 114(3):257-62. DOI: 10.1007/s11060-013-1195-2. View

Ferrara G, Kim J, Lin S, Hua J, Seto E . A Focused Review of Smartphone Diet-Tracking Apps: Usability, Functionality, Coherence With Behavior Change Theory, and Comparative Validity of Nutrient Intake and Energy Estimates. JMIR Mhealth Uhealth. 2019; 7(5):e9232. PMC: 6543803. DOI: 10.2196/mhealth.9232. View

Cleeland C, Ryan K . Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994; 23(2):129-38. View

Stinson J, Lalloo C, Harris L, Isaac L, Campbell F, Brown S . iCanCope with Pain™: User-centred design of a web- and mobile-based self-management program for youth with chronic pain based on identified health care needs. Pain Res Manag. 2014; 19(5):257-65. PMC: 4197753. DOI: 10.1155/2014/935278. View

10.

Birnie K, Campbell F, Nguyen C, Lalloo C, Tsimicalis A, Matava C . iCanCope PostOp: User-Centered Design of a Smartphone-Based App for Self-Management of Postoperative Pain in Children and Adolescents. JMIR Form Res. 2019; 3(2):e12028. PMC: 6658275. DOI: 10.2196/12028. View

11.

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

12.

Anderson J, Gutmann D . Neurofibromatosis type 1. Handb Clin Neurol. 2015; 132:75-86. DOI: 10.1016/B978-0-444-62702-5.00004-4. View

13.

Agarwal P, Gordon D, Griffith J, Kithulegoda N, Witteman H, Bhatia R . Assessing the quality of mobile applications in chronic disease management: a scoping review. NPJ Digit Med. 2021; 4(1):46. PMC: 7946941. DOI: 10.1038/s41746-021-00410-x. View

14.

Whitehead L, Seaton P . The Effectiveness of Self-Management Mobile Phone and Tablet Apps in Long-term Condition Management: A Systematic Review. J Med Internet Res. 2016; 18(5):e97. PMC: 4886099. DOI: 10.2196/jmir.4883. View

15.

North K, Riccardi V, Ferner R, Moore B, Legius E, Ratner N . Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology. 1997; 48(4):1121-7. DOI: 10.1212/wnl.48.4.1121. View

16.

Palos G, Mendoza T, Mobley G, Cantor S, Cleeland C . Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain. 2006; 7(1):49-56. DOI: 10.1016/j.jpain.2005.07.012. View

17.

Lasker J, Sogolow E, Sharim R . The role of an online community for people with a rare disease: content analysis of messages posted on a primary biliary cirrhosis mailinglist. J Med Internet Res. 2005; 7(1):e10. PMC: 1550634. DOI: 10.2196/jmir.7.1.e10. View

18.

Kodra Y, Giustini S, Divona L, Porciello R, Calvieri S, Wolkenstein P . Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patients. Dermatology. 2008; 218(3):215-20. DOI: 10.1159/000187594. View

19.

Cruz Zapata B, Fernandez-Aleman J, Idri A, Toval A . Empirical studies on usability of mHealth apps: a systematic literature review. J Med Syst. 2015; 39(2):1. DOI: 10.1007/s10916-014-0182-2. View

20.

Doyle M . Peer Support and Mentorship in a US Rare Disease Community: Findings from the Cystinosis in Emerging Adulthood Study. Patient. 2014; 8(1):65-73. DOI: 10.1007/s40271-014-0085-9. View